Indian Temozolomide Exporters: Complete Supplier Ranking with Market Share — 133 Manufacturers (2026) — TransData Nexus

Q: Who is the largest temozolomide supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the largest temozolomide exporter from India with a 62.4% market share and export value of $14.7M.

Q: How many temozolomide suppliers are there in India?

There are 133 active temozolomide exporters in India, collectively shipping $23.5M worth of temozolomide across 1,261 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top temozolomide suppliers from India?

The top 5 temozolomide suppliers from India — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, JODAS EXPOIM PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 89.8% of total temozolomide export value from India.

Suresh Sormare

Temozolomide

India Pharmaceutical Trade Intelligence

$23.5M133 Suppliers90 CountriesHS 30049049

ExportsIndia → CANADA31.8%India → BELGIUM22.5%

ImportsBELGIUM → India$34.4K NETHERLANDS → India$30.5K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Temozolomide Suppliers from India (2026) — 133 Exporters, $23.5M Market | TransData Nexus | TransData Nexus

Who Exports Temozolomide from India — 133 Suppliers Behind a $23.5M Market

India's temozolomide export market is supplied by 133 active exporters who collectively shipped $23.5M across 1,261 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 62.4% market share, followed by SUN PHARMACEUTICAL INDUSTRIES LTD and JODAS EXPOIM PRIVATE LIMITED. The top 5 suppliers together control 89.8% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Temozolomide Suppliers & Exporters — 133 manufacturers, $23.5M export market, top destinations and formulations — Temozolomide supplier data — 133 exporters · $23.5M market · 1,261 shipmentsTransData Nexus · Indian Customs Data

Top Temozolomide Exporters from India — Ranked by Export Value

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading temozolomide exporter from India, holding a 62.4% share of the $23.5M market across 1,261 shipments from 133 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, JODAS EXPOIM PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED — collectively control 89.8% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (62.4%), SUN PHARMACEUTICAL INDUSTRIES LTD (8.4%), JODAS EXPOIM PRIVATE LIMITED (8.4%), RELIANCE LIFE SCIENCES PRIVATE LIMITED (7.1%), INTAS PHARMACEUTICALS LIMITED (3.5%).

Top Temozolomide Exporters from India

Ranked by export value · 133 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Temozolomide Exporters from India — Ranked by Export Value. 133 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Temozolomide exporters

Certification and compliance status for top Temozolomide suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Sun Pharmaceutical Industries Limited	Warning Letter issued in	Yes, certified in Ap	Yes	89 approvals as of August 2018	FDA Warning Letter cited CGMP violations at Dadra facility in June 2024.
Intas Pharmaceuticals Limited	Not Listed	Yes, certified in Ap	Yes	Not Listed	WHO-GMP certified in April 2007; no FDA Warning Letters found.

TransData Nexus reviewed the regulatory standing of 2 leading Temozolomide exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Temozolomide sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's pharmaceutical ecosystem is supported by numerous API manufacturers and research institutions, fostering innovation and large-scale production. Companies in Hyderabad are instrumental in supplying high-quality APIs, including those for oncology drugs like Temozolomide, to both domestic and international markets.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat has emerged as a significant hub for pharmaceutical formulations. This region hosts several leading pharmaceutical companies specializing in the development and manufacturing of finished dosage forms. The presence of state-of-the-art facilities and a skilled workforce enables the production of complex formulations, including Temozolomide capsules, meeting stringent global regulatory standards.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products. With its proximity to major ports and well-established logistics infrastructure, this region facilitates the efficient export of pharmaceuticals to international markets. Companies operating here are adept at navigating global regulatory requirements, ensuring timely delivery of products like Temozolomide to countries worldwide.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Temozolomide exporters from India

March 2023

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Concert Pharmaceuticals for $576 million

On March 6, 2023, Sun Pharmaceutical Industries Limited completed the acquisition of Concert Pharmaceuticals, Inc., a U.S.-based biotechnology company specializing in treatments for alopecia areata. IMPACT: This acquisition is expected to enhance Sun Pharma's research capabilities, potentially leading to expanded production and export of oncology drugs, including Temozolomide.

Impact: This acquisition is expected to enhance Sun Pharma's research capabilities, potentially leading to expanded production and export of oncology drugs, including Temozolomide.

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

In March 2025, Sun Pharmaceutical Industries Limited announced the acquisition of Checkpoint Therapeutics, a U.S.-based company focused on immunotherapy and targeted oncology treatments. IMPACT: This acquisition is anticipated to strengthen Sun Pharma's oncology portfolio, potentially increasing the export of oncology drugs, including Temozolomide.

Impact: This acquisition is anticipated to strengthen Sun Pharma's oncology portfolio, potentially increasing the export of oncology drugs, including Temozolomide.

Common Questions — Temozolomide Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which temozolomide supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 311 recorded shipments worth $14.7M. SUN PHARMACEUTICAL INDUSTRIES LTD (19 shipments) and JODAS EXPOIM PRIVATE LIMITED (35 shipments) are also established high-volume exporters.

Q How many temozolomide manufacturers are there in India?

India has 133 active temozolomide exporters with a combined export market of $23.5M across 1,261 shipments to 90 countries. The top 5 suppliers hold 89.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for temozolomide from India?

Average FOB unit price: $18.75 per unit, ranging from $0.01 to $6092.57. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Temozolomide

Temozolomide

Who Exports Temozolomide from India — 133 Suppliers Behind a $23.5M Market

Top Temozolomide Exporters from India — Ranked by Export Value

Top Temozolomide Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Concert Pharmaceuticals for $576 million

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Temozolomide Suppliers from India

Q Which temozolomide supplier from India is the most reliable for bulk orders?

Q How many temozolomide manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for temozolomide from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Intas Pharmaceuticals Limited — Intas acquires Teva's UK & Ireland assets for $764 million

Analysis Methodology